Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
MedX Health ( (TSE:MDX) ) has provided an update.
MedX Health Corp. has announced an extension for the closing date of its non-brokered private placement, aiming to raise up to $2.5 million. The funds will be used to further develop its SIAscopy® on DermSecure® telemedicine platform and expand its technology into the occupational health market. The placement, which is open to accredited investors, will consist of units priced at $0.075 each, with each unit including a common share and a share purchase warrant. The extension allows the company additional time to meet the conditions required for closing, including regulatory approvals.
More about MedX Health
MedX Health Corp., based in Ontario, Canada, specializes in non-invasive skin assessment and teledermatology. The company is known for its SIAscopy® technology, integrated into the DermSecure® platform, which allows for pain-free, accurate imaging of skin lesions for rapid dermatologist review. MedX’s products are approved for use in multiple countries, including Canada, the U.S., and the European Union.
Average Trading Volume: 150,921
Technical Sentiment Signal: Sell
Current Market Cap: C$21.13M
For a thorough assessment of MDX stock, go to TipRanks’ Stock Analysis page.